ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/06/21 | 2,537 | 2,553 | 2,526 | 2,533 | -4 | -0.2% | 105,300 |
2023/06/20 | 2,545 | 2,551 | 2,507 | 2,537 | -32 | -1.2% | 71,300 |
2023/06/19 | 2,555 | 2,569 | 2,537 | 2,569 | +14 | +0.5% | 51,000 |
2023/06/16 | 2,490 | 2,577 | 2,488 | 2,555 | +72 | +2.9% | 268,900 |
2023/06/15 | 2,518 | 2,518 | 2,474 | 2,483 | -52 | -2.1% | 104,000 |
2023/06/14 | 2,590 | 2,592 | 2,535 | 2,535 | -48 | -1.9% | 90,400 |
2023/06/13 | 2,558 | 2,600 | 2,558 | 2,583 | +37 | +1.5% | 117,700 |
2023/06/12 | 2,524 | 2,577 | 2,520 | 2,546 | +30 | +1.2% | 195,900 |
2023/06/09 | 2,498 | 2,533 | 2,483 | 2,516 | +51 | +2.1% | 158,300 |
2023/06/08 | 2,460 | 2,492 | 2,449 | 2,465 | +12 | +0.5% | 107,700 |
2023/06/07 | 2,449 | 2,485 | 2,444 | 2,453 | +36 | +1.5% | 118,200 |
2023/06/06 | 2,392 | 2,421 | 2,369 | 2,417 | +17 | +0.7% | 62,700 |
2023/06/05 | 2,445 | 2,450 | 2,393 | 2,400 | +12 | +0.5% | 88,600 |
2023/06/02 | 2,365 | 2,391 | 2,345 | 2,388 | +53 | +2.3% | 82,400 |
2023/06/01 | 2,342 | 2,362 | 2,333 | 2,335 | -4 | -0.2% | 83,900 |
2023/05/31 | 2,364 | 2,403 | 2,327 | 2,339 | -64 | -2.7% | 206,900 |
2023/05/30 | 2,430 | 2,442 | 2,389 | 2,403 | -48 | -2% | 79,800 |
2023/05/29 | 2,483 | 2,483 | 2,441 | 2,451 | -24 | -1% | 66,000 |
2023/05/26 | 2,506 | 2,508 | 2,467 | 2,475 | -40 | -1.6% | 87,300 |
2023/05/25 | 2,498 | 2,527 | 2,485 | 2,515 | ±0 | ±0% | 70,300 |
2023/05/24 | 2,530 | 2,538 | 2,515 | 2,515 | -12 | -0.5% | 41,200 |
2023/05/23 | 2,527 | 2,541 | 2,507 | 2,527 | +3 | +0.1% | 65,800 |
2023/05/22 | 2,514 | 2,535 | 2,502 | 2,524 | +17 | +0.7% | 40,500 |
2023/05/19 | 2,525 | 2,525 | 2,492 | 2,507 | -18 | -0.7% | 78,400 |
2023/05/18 | 2,540 | 2,540 | 2,475 | 2,525 | -9 | -0.4% | 90,500 |
2023/05/17 | 2,535 | 2,547 | 2,512 | 2,534 | -1 | ±0% | 65,100 |
2023/05/16 | 2,530 | 2,535 | 2,504 | 2,535 | +10 | +0.4% | 59,800 |
2023/05/15 | 2,468 | 2,525 | 2,464 | 2,525 | +79 | +3.2% | 159,000 |
2023/05/12 | 2,431 | 2,448 | 2,398 | 2,446 | +32 | +1.3% | 105,800 |
2023/05/11 | 2,435 | 2,466 | 2,404 | 2,414 | -54 | -2.2% | 124,800 |
2023/05/10 | 2,470 | 2,480 | 2,454 | 2,468 | -2 | -0.1% | 89,200 |
2023/05/09 | 2,468 | 2,475 | 2,449 | 2,470 | +2 | +0.1% | 69,700 |
2023/05/08 | 2,454 | 2,478 | 2,451 | 2,468 | -3 | -0.1% | 82,200 |
2023/05/02 | 2,472 | 2,487 | 2,452 | 2,471 | +21 | +0.9% | 95,900 |
2023/05/01 | 2,425 | 2,467 | 2,425 | 2,450 | +20 | +0.8% | 66,400 |
2023/04/28 | 2,415 | 2,430 | 2,404 | 2,430 | +41 | +1.7% | 69,100 |
2023/04/27 | 2,374 | 2,405 | 2,355 | 2,389 | -6 | -0.3% | 85,200 |
2023/04/26 | 2,387 | 2,404 | 2,377 | 2,395 | -16 | -0.7% | 43,800 |
2023/04/25 | 2,415 | 2,453 | 2,407 | 2,411 | +3 | +0.1% | 126,800 |
2023/04/24 | 2,382 | 2,417 | 2,374 | 2,408 | +32 | +1.3% | 114,100 |
2023/04/21 | 2,355 | 2,394 | 2,347 | 2,376 | +25 | +1.1% | 93,300 |
2023/04/20 | 2,339 | 2,370 | 2,339 | 2,351 | +7 | +0.3% | 80,000 |
2023/04/19 | 2,341 | 2,353 | 2,329 | 2,344 | -27 | -1.1% | 93,900 |
2023/04/18 | 2,355 | 2,376 | 2,344 | 2,371 | +16 | +0.7% | 77,200 |
2023/04/17 | 2,382 | 2,382 | 2,354 | 2,355 | -24 | -1% | 86,100 |
2023/04/14 | 2,360 | 2,383 | 2,358 | 2,379 | +32 | +1.4% | 68,500 |
2023/04/13 | 2,323 | 2,353 | 2,318 | 2,347 | +31 | +1.3% | 62,800 |
2023/04/12 | 2,315 | 2,338 | 2,312 | 2,316 | +16 | +0.7% | 54,200 |
2023/04/11 | 2,279 | 2,302 | 2,273 | 2,300 | +27 | +1.2% | 75,300 |
2023/04/10 | 2,270 | 2,278 | 2,257 | 2,273 | +23 | +1% | 35,400 |
351~
400
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム